Director of Hepion Pharmaceuticals, Inc. (NYSE:HEPA), Wijngaard Peter, buys 20,000 shares worth $38,200

According to Hepion Pharmaceuticals, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 21 09:17 AM, company Director, Wijngaard Peter disclosed buying 20,000 shares at a cost of $1.91. At the time of this transaction (Dec 18), this trade was worth $38,200 in total. As of Dec 18, Wijngaard Peter now owns 20,000 shares in total worth about $39,800.0.

For the last few recent trades made by Hepion Pharmaceuticals, Inc. (NYSE:HEPA) Director, Wijngaard Peter, we have the following information:

Posted by George Daniels on Monday December 21 2020, 10:20 AM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0